Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol XR in Heart Failure With Normal Ejection Fraction
NCT03882710Phase 2Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jan 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure with preserved ejection fraction (HFpEF) comparing Metoprolol XR with Placebo (2 arms). Primary endpoint: Proportion of patients showing improvement of ≥ 1 in NYHA class at 12 weeks. Started Jan 2010; status: completed.
02
Drugs
metoprolol
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT03882710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03882710.